Background: A study was undertaken to investigate the relationship between the vascular access route and the occurrence of diffusion-weighted imaging (DWI) lesions as well as puncture site complications in patients undergoing elective endovascular treatment (EVT) for cerebral aneurysms. Methods: This retrospective single-center study included all consecutive patients who underwent elective EVT of unruptured cerebral aneurysms via transradial (TRA) or transfemoral (TFA) access between January 2024 and April 2025. Postprocedural MRI was assessed for new DWI lesions. Univariable and multivariable regression analysis was performed to identify predictors for DWI lesions. Results: A total of 199 patients (50.3% TRA, 49.7% TFA) were included. New DWI lesions were detected in 53% of patients. There was no difference in the rates of silent or symptomatic DWI lesions between the two groups (60% vs 50%, P=0.15; and 5% vs 10%, P=0.19, respectively). In a multivariate regression analysis, higher age (aOR 1.04 per year, 95% CI 1.01 to 1.06, P=0.009), longer procedure time (aOR 1.01 per minute, 95% CI 1 to 1.02, P=0.023), and the use of adjunctive techniques such as stent- and balloon-assisted coiling (aOR 6.96, 95% CI 1.73 to 27.99, P=0.006) were independent predictors of postprocedural DWI lesions, while no association was found for the access route. Puncture site complications were comparable between TFA and TRA groups (TRA 3% vs TFA 8%, P=0.12). Conclusion: TRA is a safe and feasible alternative to TFA for elective EVT. The risk of postprocedural DWI lesions is primarily influenced by patient age and procedural complexity rather than access route. These findings support the use of TRA in appropriately selected patients, particularly when vascular anatomy or patient preference favors this approach.
Purpose: To identify patient- and procedure-related factors associated with radiation exposure during middle meningeal artery (MMA) embolization for chronic subdural hematoma (cSDH), with particular focus on embolic agent (particle vs. liquid) and arterial access route (transradial vs. transfemoral). Methods: In this retrospective single-center cohort study, we included all patients who underwent MMA embolization for cSDH between February 2021 and October 2025. MMA embolization was performed by fourteen experienced board-certified neuroradiologists. The primary outcome was dose area product (DAP, Gy · cm 2 ). Univariable and multivariable linear regression analyses were performed to assess associations between DAP and age, sex, access route, treated side (unilateral vs bilateral), embolic agent, anesthesia, interventionalist, and guiding catheter. Results: A total of 112 patients (median age 81 years; 20% female) were included; 69 (62%) underwent embolization with particles and 43 (38%) with liquid agents. Transradial access was used in 17 (15%) and transfemoral access in 95 (85%) procedures. Overall median (IQR) DAP was 74.7 Gy · cm 2 (55.6–102.4), with 65.5 Gy · cm 2 (50.6–82.0) for unilateral and 107.6 Gy · cm 2 (84.1–161.6) for bilateral embolization. Univariable analyses showed no significant association between DAP and age, sex, embolic agent, access route, anesthesia, guiding catheter, or interventionalist. In multivariable analysis, unilateral right and left MMA embolization remained independently associated with significantly lower DAP compared with bilateral procedures, while embolic agent and access route were not significantly associated with radiation exposure. Conclusion: In MMA embolization for cSDH, radiation exposure is primarily driven by procedural extent, with higher DAP in bilateral than in unilateral embolization, whereas the choice of embolic material and arterial access route is not associated with radiation dose. These findings support selecting embolic agents and access routes based on anatomical and clinical considerations rather than radiation concerns.
Background: Cerebral vasospasm (CV) as a complication after aneurysmal subarachnoid hemorrhage (aSAH) is a major determinant of secondary vasospasm-associated ischemic infarction (SVS-I) and poor outcome. Data on the interplay among the onset of CV, SVS-I, and in-hospital mortality remain limited. Methods: We conducted a retrospective, single-center study including patients admitted with aSAH between January 2016 and May 2024 who developed treatment-relevant CV. The primary outcome was the rate of in-hospital mortality. The relationship between the onset of CV, demographics, imaging, and treatment data and the primary outcome was analyzed using logistic regression. A confounder-adjusted mediation analysis was performed to quantify the extent to which the effect of time to CV onset on in-hospital mortality was mediated by SVS-I. Results: A total of 165 patients with aSAH and treatment-relevant CV were included. The median age was 55 (IQR, 48–64), and 67.2% (111) were female. Of the included patients, 13.3% (22) died during hospitalization. In multivariable logistic regression analysis, earlier onset of treatment-relevant CV (adjusted odds ratio [aOR] 0.79; 95% CI, 0.66–0.95) and the occurrence of SVS-I (aOR 13.47; 95% CI, 2.78–65.3) were associated with the primary outcome. Mediation analysis indicated that SVS-I accounted for 28% of the effect of earlier onset of CV on in-hospital mortality. Conclusions: Twenty-eight percent of the effect of earlier onset of cerebral vasospasm on in-hospital mortality was mediated by secondary ischemic infarction. Targeting patients with early-onset vasospasm and the associated risk of infarction may reduce in-hospital mortality following aneurysmal subarachnoid hemorrhage.
Background: To evaluate the impact of Woven EndoBridge (WEB) device protrusion on the occurrence and number of postprocedural diffusion-weighted imaging (DWI) lesions in patients with unruptured intracranial aneurysms. Methods: This retrospective single-center study included all consecutive patients with unruptured intracranial aneurysms treated with the WEB device between January 2019 and May 2026. Postprocedural brain MRI, including DWI, was performed within 24–72 hours after treatment. The presence and number of postprocedural DWI lesions, as well as the WEB protrusion, were independently assessed by two experienced board-certified neuroradiologists. Univariable and multivariable linear regression analyses were performed to identify factors associated with the number of postprocedural DWI lesions. Logistic regression analyses were used to assess factors associated with the occurrence of DWI lesions. Results: WEB protrusion was observed in 26/117 patients (22%). Postprocedural DWI lesions occurred in 51/117 patients (44%), without a significant difference between patients with and without protrusion (13/26 (50%) vs 38/91 (42%), P=0.408). However, the mean number of postprocedural DWI lesions was significantly higher in patients with WEB protrusion compared with those without protrusion (4.6±10.2 vs 1.5±3.2, P=0.013). In the multivariable linear regression model, only WEB protrusion was significantly associated with the number of postprocedural DWI lesions (β=3.03 (0.49–5.57), P=0.02). Conclusion: WEB protrusion was independently associated with the number of DWI lesions after treatment of unruptured intracranial aneurysms. In contrast, procedure duration was associated with DWI lesion occurrence, whereas repositioning attempts showed no independent association with either lesion occurrence or lesion burden.